000 | 01404 a2200397 4500 | ||
---|---|---|---|
005 | 20250513054651.0 | ||
264 | 0 | _c19940725 | |
008 | 199407s 0 0 eng d | ||
022 | _a0378-5122 | ||
024 | 7 |
_a10.1016/0378-5122(94)90127-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWolfe, B M | |
245 | 0 | 0 |
_aEarly effects of continuous low-dosage all-norgestrel administered alone or with estrogen. _h[electronic resource] |
260 |
_bMaturitas _cMar 1994 |
||
300 |
_a207-19 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 |
_aCholesterol, VLDL _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEndometrium _xdrug effects |
650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFlushing _xphysiopathology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNorgestrel _xadministration & dosage |
650 | 0 | 4 |
_aPostmenopause _xblood |
650 | 0 | 4 |
_aTriglycerides _xblood |
700 | 1 | _aPlunkett, E R | |
773 | 0 |
_tMaturitas _gvol. 18 _gno. 3 _gp. 207-19 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0378-5122(94)90127-9 _zAvailable from publisher's website |
999 |
_c8014831 _d8014831 |